Filing Flows › Comparisons › DRIO vs BTCY
DarioHealth vs Biotricity: DRIO and BTCY compared
DarioHealth is the larger company: $5.2M of revenue in its latest quarter (Q2 2026) against $4.3M for Biotricity (Q1 FY27). Biotricity is growing faster (+10% against -4% a year earlier). Biotricity is more profitable, with an operating margin of 3.7% against -125.1%.
Where the money goes: DRIO and BTCY
DarioHealth (DRIO) · Q2 2026
DarioHealth, Q2 2026: revenue $5.2M (-4% year over year), operating margin -125.1%, net loss $7.9M, operating cash flow −$6.1M. The chart follows the revenue to costs, profit and cash.
Biotricity (BTCY) · Q1 FY27
Biotricity, Q1 FY27: revenue $4.3M (+10% year over year), operating margin 3.7%, net loss $959K, operating cash flow $507K. The chart follows the revenue to costs, profit and cash.
| DarioHealth (DRIO) | Biotricity (BTCY) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $5.2M | $4.3M |
| Revenue growth, Y/Y | -4% | +10% |
| Operating margin | -125.1% | 3.7% |
| Net earnings | −$7.9M | −$959K |
| Net margin | -153.1% | -22.4% |
| Operating cash flow | −$6.1M | $507K |
Where the revenue comes from
DarioHealth
- Hardware and Consumable Products: $2.6M (50%)
- Services: $2.6M (50%)
Biotricity
- Technology Fees: $4.2M (97%)
- Device Sales: $111K (3%)
Questions
Which is bigger, DarioHealth or Biotricity?
DarioHealth is the larger company: $5.2M of revenue in its latest quarter (Q2 2026) against $4.3M for Biotricity (Q1 FY27).
Is DarioHealth or Biotricity growing faster?
Biotricity is growing faster (+10% against -4% a year earlier).
Which is more profitable, DarioHealth or Biotricity?
Biotricity is more profitable, with an operating margin of 3.7% against -125.1%.
More: DarioHealth earnings · how DarioHealth makes money · Biotricity earnings · how Biotricity makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 19, 2026). Fiscal quarters can end on different dates. Not investment advice.